(0.35%) 5 117.62 points
(0.42%) 38 402 points
(0.48%) 16 004 points
(-1.61%) $82.50
(4.94%) $2.02
(0.20%) $2 351.80
(0.21%) $27.59
(4.16%) $960.45
(-0.22%) $0.933
(-0.36%) $10.99
(-0.54%) $0.796
(1.69%) $93.42
Live Chart Being Loaded With Signals
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally...
Stats | |
---|---|
Dagens volum | 216 849 |
Gjennomsnittsvolum | 215 038 |
Markedsverdi | 51.23M |
EPS | £0 ( 2024-04-11 ) |
Last Dividend | £0.0400 ( 2018-05-24 ) |
Next Dividend | £0 ( N/A ) |
P/E | 40.50 |
ATR14 | £0.452 (1.11%) |
Venture Life Group PLC Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Venture Life Group PLC Økonomi
Annual | 2023 |
Omsetning: | £51.41M |
Bruttogevinst: | £13.51M (26.27 %) |
EPS: | £0.00730 |
FY | 2023 |
Omsetning: | £51.41M |
Bruttogevinst: | £13.51M (26.27 %) |
EPS: | £0.00730 |
FY | 2022 |
Omsetning: | £43.98M |
Bruttogevinst: | £17.67M (40.17 %) |
EPS: | £0.00410 |
FY | 2021 |
Omsetning: | £32.76M |
Bruttogevinst: | £12.96M (39.55 %) |
EPS: | £0.0278 |
Financial Reports:
No articles found.
Venture Life Group PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.0400 | 2014-06-11 |
Last Dividend | £0.0400 | 2018-05-24 |
Next Dividend | £0 | N/A |
Payout Date | 2018-06-22 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | £0.200 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.4 | -- |
Div. Sustainability Score | 8.11 | |
Div.Growth Potential Score | 4.20 | |
Div. Directional Score | 6.15 | -- |
Year | Amount | Yield |
---|---|---|
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £0.0400 | 0.10% |
2019 | £0 | 0.00% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RDW.L | Dividend Knight | 2023-09-21 | Annually | 31 | 3.30% | |
GRG.L | Dividend Knight | 2023-09-07 | Semi-Annually | 32 | 1.71% | |
APTD.L | Dividend Knight | 2023-08-03 | Semi-Annually | 32 | 0.82% | |
TSCO.L | Dividend King | 2023-05-11 | Semi-Annually | 32 | 4.53% | |
MFX.L | Dividend Knight | 2023-06-15 | Annually | 4 | 1.28% | |
CSN.L | Dividend Knight | 2023-09-28 | Semi-Annually | 21 | 4.56% | |
SBRE.L | Dividend Knight | 2023-08-17 | Semi-Annually | 7 | 2.15% | |
HSX.L | Dividend Knight | 2023-08-17 | Annually | 18 | 1.61% | |
BDEV.L | Dividend King | 2023-09-28 | Semi-Annually | 32 | 2.43% | |
WHR.L | Dividend Knight | 2023-09-07 | Quarterly | 7 | 2.99% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0179 | 1.500 | 9.64 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00771 | 1.200 | 9.74 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0123 | 1.500 | -0.975 | -1.462 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.084 | 0.800 | 9.58 | 7.67 | [1 - 3] |
quickRatioTTM | 0.735 | 0.800 | -0.380 | -0.304 | [0.8 - 2.5] |
cashRatioTTM | 0.189 | 1.500 | -0.0587 | -0.0880 | [0.2 - 2] |
debtRatioTTM | 0.204 | -1.500 | 6.60 | -9.90 | [0 - 0.6] |
interestCoverageTTM | 3.00 | 1.000 | -0.00174 | -0.00174 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0540 | 2.00 | 9.98 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0350 | 2.00 | 9.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.320 | -1.500 | 8.72 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.263 | 1.000 | 8.95 | 8.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0865 | 1.000 | -0.271 | -0.271 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.280 | 1.000 | 9.56 | 9.56 | [0.2 - 2] |
assetTurnoverTTM | 0.430 | 0.800 | -0.465 | -0.372 | [0.5 - 2] |
Total Score | 8.11 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 57.00 | 1.000 | 4.34 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0123 | 2.50 | -0.627 | -1.462 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0350 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0540 | 2.00 | 9.98 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 77.45 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.133 | 1.000 | 9.18 | 0 | [0.1 - 0.5] |
Total Score | 4.20 |
Venture Life Group PLC
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.